COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated [...]
Avouac, J., Drumez, E., Hachulla, E., Seror, R., Georgin-Lavialle, S., El Mahou, S., et al. (2021). Voir la publication Background :...
top of page
![COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated [...]](https://static.wixstatic.com/media/5bb25034a8bb415fb3d37edd270a7f96.jpg/v1/fill/w_268,h_201,fp_0.50_0.50,q_90,enc_auto/5bb25034a8bb415fb3d37edd270a7f96.jpg)
![Severity of COVID-19 and survival in patients with rheumatic and inflammatory diseases [...]](https://static.wixstatic.com/media/11062b_196865e19f3c418e9e36c9163e840520~mv2_d_6016_4016_s_4_2.jpg/v1/fill/w_268,h_201,fp_0.50_0.50,q_90,enc_auto/11062b_196865e19f3c418e9e36c9163e840520~mv2_d_6016_4016_s_4_2.jpg)
- 13 oct. 2020
Severity of COVID-19 and survival in patients with rheumatic and inflammatory diseases [...]
Objectives : There is little known about the impact of SARS-CoV-2 on patients with inflammatory rheumatic and musculoskeletal diseases ...
- 16 avr. 2020
FAI2R | RMD-cohort | COVID-19 | e-cohorte
RMD-cohorte est une étude vise à évaluer la fréquence des formes sévères de COVID-19 et les facteurs de risque associés à des issues ...
- 15 avr. 2020
Cohorte FAI2R - COVID19
Etude du suivi et prise en charge clinique des patients atteints d’une maladie auto-immune ou auto-inflammatoire ayant présenté ou ...
bottom of page